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Abstract
Background: Many diseases associated with bone marrow transplantation (BMT) are caused by transplanted hematopoietic
cells, and the onset of these diseases occurs after homing of donor cells in the initial phase after BMT. Noninvasive
observation of donor cell homing shortly after transplantation is potentially valuable for improving therapeutic outcomes of
BMT by diagnosing the early stages of these diseases.
Methodology/Principal Findings: Freshly harvested near-infrared fluorescence-labeled cells were noninvasively observed
for 24 h after BMT using a photon counting device to track their homing process. In a congenic BMT model, the homing of
Alexa Fluor 750-labeled donor cells in the tibia was detected less than 1 h after BMT. In addition, subsequent cell
distribution in an intraBM BMT model was successfully monitored for the first time using this method. In the allogeneic BMT
model, T-cell depletion decreased the near-infrared fluorescence (NIRF) signals of the reticuloendothelial system.
Conclusions/Significance: This approach in several murine BMT models revealed that the transplanted cells homed within
24 h after transplantation. NIRF labeling is useful for tracking transplanted cells in the initial phase after BMT, and this
approach can contribute to in vivo studies aimed at improving the therapeutic outcomes of BMT.
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Introduction
Bone marrow transplantation (BMT) is an important procedure
for curing hematological malignancies, although engraftment
failure [1] and graft-versus-host disease (GVHD) [2] remain
serious complications following allogeneic BMT. To examine
these complications, it is important to monitor the transplanted
donor cells in the initial phase after BMT because donor cell
homing is a rapid process. Homing is defined as the anchoring of
hematopoietic cells in their niche before cell proliferation [3].
Results of a colony-forming assay revealed that donor cell homing
occurs within minutes or a few hours, rather than days, after BMT
[4]. BMT-associated complications are suspected to begin just
after homing of the donor cells; for example, in studies of
engraftment failure, homing of hematopoietic stem cells (HSCs) is
crucial and is the first step in hematopoietic reconstitution [5]. In
acute GVHD (aGVHD), T-cell activation by host antigen-
presenting cells [6,7] begins after homing in the reticuloendothelial
system, and this process starts within a few days after BMT in
murine GVHD models [8].
Recent molecular imaging techniques have facilitated significant
advances in noninvasive optical imaging [9], which enable
tracking of transplanted hematopoietic cells with greater accuracy
in vivo. Bioluminescence imaging can precisely analyze the
processes during BMT [10]. However, until now, bioluminescence
imaging has provided sparse spatiotemporal information for donor
cell homing in the initial phase after BMT.
In this study, we directly labeled donor BM cells using a near-
infrared fluorescence (NIRF) dye with high tissue permeability and
monitored the homing of transplanted cells shortly after BMT
using a noninvasive whole-body imaging device IVIS-Spectrum.
The overall results provide information regarding the homing of
donor cells after BMT and intraBM-BMT (IBM-BMT), and the
onset of GVHD. Noninvasive tracking of transplanted donor cells
in the initial phase after BMT enables acquisition of spatiotem-
poral information regarding HSC homing, which can help identify
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11114factors supporting HSC homing and mechanisms of hematopoietic
reconstitution.
Materials and Methods
Ethics statement
All animal experiments in this study were performed with the
approval of the Animal Experiment Committees of Kyoto
University, Graduate School of Medicine. The approval number
of the experiment is Med Kyo 09247. Approved experiments
included use of transgenic mice and primary cells, cell transplan-
tation, in vivo and ex vivo optical imaging, and UV irradiation.
Mice
Balb/c nu/nu (H-2
d, Thy 1.2), Balb/c (H-2
d, Thy 1.2), C57BL/
6 (H-2
b, Thy 1.2), and FVB/N (H-2
q, Thy 1.1) mice were
purchased from Japan SLC Inc. (Hamamatsu, Japan). Enhanced
green fluorescent protein (EGFP) transgenic mice were generated
by injecting the CAAG-EGFP expression vector into a one-cell
embryo of an ICR closed colony (ICR/EGFP) [11], followed by
breeding in an SPF animal facility. All mice were 7–9 weeks of age
and were fasted according to our original fasting protocol from the
day before BMT until 24 h after BMT (Supplemental Fig. S1) for
suppression of autofluorescence from food particles in the
gastrointestinal (GI) tract.
Cell preparation for transplantation and in vitro assays
BM cells were prepared from the medullary cavities of the
humerus, femur, and tibia. Splenocytes were prepared by
homogenization of the spleen. BM mononuclear cells (BM-MNCs)
and spleen mononuclear cells (Sp-MNCs) were obtained by
density gradient centrifugation using Lympholyte-M solution
(Cedarlane Labs, Hornby, ON, Canada). T-cell-depleted (TCD)
BM-MNCs were obtained by negative selection using Thy1.2
+
microbeads (Miltenyi Biotech, Auburn, CA, USA).
NIRF and 5-(6)-carboxyfluorescein diacetate succinimidyl
ester (CFSE) labeling
Cy5.5 monofunctional dye (peak excitation: 675 nm, peak
emission: 694 nm; GE Healthcare UK Ltd, Buckinghamshire,
UK) and Alexa Fluor 750 carboxylic acid, succinimidyl ester
(AF750) (peak excitation: 749 nm, peak emission: 775 nm; Invitro-
gen, Eugene, OR, USA) were dissolved in N, N-dimethylforma-
mide. To prepare Cy5.5- or AF750-labeled cells, BM-MNCs and
Sp-MNCs were incubated with Cy5.5 (0.4 mg/mL) or AF750
(0.1 mg/mL) for 15 min at 37uC under 5% CO2. The cells were
washed twice with phosphate-buffered saline (PBS) and then once
with 10 mM Tris in PBS to disturb the active groups. For CFSE
(Invitrogen)labeling,the cellswereincubatedin5 mMCFSEinPBS
for 10 min at 37uC, followed by washing with excess ice-cold PBS
on ice for 5 min to quench staining. The cells were then washed 3
times with PBS. To prepare CFSE and NIRF double-positive cells,
CFSE staining was performed before NIRF labeling.
Cell proliferation assays
NIRF-labeled Sp-MNCs (1610
5) were seeded in a 96-well plate
with 100 mL of phenol red-free RPMI 1640 (Wako Pure Chemical
Industries Ltd., Osaka, Japan) supplemented with 1 mM sodium
pyruvate, 10 mM HEPES, 100 units/mL penicillin, 100 mg/mL
streptomycin, 50 mM mercaptoethanol, and 10% FCS. To
stimulate splenocyte proliferation, recombinant mouse IL-2
(mIL-2) (20 ng/mL; R&D Systems, Minneapolis, MN, USA)
and anti-CD3/CD28 antibody-coated beads (Dynabeads mouse
CD3/CD28 T-cell expander; Invitrogen Dynal AS, Oslo, Nor-
way) were added to the medium. The CD3/CD28 T-cell
expander was used at a 1:1 bead-to-cell ratio according to the
manufacturer’s instructions. The viable cell number was analyzed
as previously described [12] with slight modifications. The
absorbance (450 nm) was measured 3 h after adding the cell-
counting reagent.
Analysis of clonogenic myeloid and erythroid progenitors
BM cells (2610
4) were harvested from 6- to 8-week-old Balb/c
nu/nu mice and cultured in Methocult GF M3434 (Stem Cell
Technologies, Vancouver, BC, Canada) according to the manu-
facturer’s instructions after NIRF labeling. Granulocyte-macro-
phage colony-forming units (GM-CFUs); erythroid burst-forming
units (BFU-Es); and granulocyte, erythrocyte, macrophage, and
megakaryocyte colony-forming units (GEMM-CFUs) were scored
after 7 days in culture.
Fluorescence-activated cell sorter (FACS) analyses
FACS data were obtained using a Canto II flow cytometer
(Becton Dickinson, Mountain View, CA, USA) and analyzed using
FACSDiva (Becton Dickinson) or FlowJo software (TreeStar,
Ashland, OR, USA). A red helium-neon (633 nm) laser was used
for excitation of Cy5.5 (analyzed using an APC filter) and AF750
(analyzed using an APC-Cy7 filter). NIRF-labeled ICR/EGFP BM-
MNCs were used for analysis of chimerism of transplanted cells.
Antibodies against FITC-conjugated Thy1.1 (CD90.1) and PE-
conjugated Thy1.2 (CD90.2) were purchased from BD Pharmin-
gen, San Diego, CA, USA. AF750-labeled Balb/c Thy1.2
+ cells
(1610
6) were mixed with unlabeled FVB/N Thy1.1
+ cells (1610
6)
ina 1:1ratioandincubated togetherinPBSat37uCfor3 h,and the
AF750 intensity of Thy1.1
+ and Thy1.2
+ cells was determined. We
estimated the percentages of EGFP
+ cells in the tibiae and
peripheral blood of the recipients at 24, 48, and 72 h after BMT.
Erythrocytes were removed using ACK lysis buffer (Invitrogen).
DNA content was analyzed as previously described [13].
Pathological examinations
For ex vivo analyses of the chimerism of transplanted EGFP
+
cells in the tibiae, the recipient mice were sacrificed at 24, 48, or
72 h after BMT. BM cells were flushed from the tibiae using PBS
and dyed with 100 mg/mL DAPI (Sigma-Aldrich, St. Louis, MO,
USA). These cells were then observed with an inverted fluorescent
microscope. To detect EGFP
+ cells in the organs after BMT, the
Balb/c nu/nu mice receiving ICR/EGFP BM-MNCs were
sacrificed at 24, 48, or 72 h after BMT. Organs from the mice
were then removed, fixed in 10% formalin, and embedded in
paraffin. Furthermore, 3-mm-thick sections were deparaffinized
and incubated with blocking solution (1% Block Ace; Dainippon
Pharmaceutical Co. Ltd., Osaka, Japan) for 15 min at room
temperature. Sections were incubated with polyclonal rabbit anti-
EGFP antibody (1:1000 dilution in PBS; Abcam, Cambridge, MA,
USA) at 4uC overnight and then with FITC-conjugated swine
anti-rabbit immunoglobulin (1:30 dilution in PBS; Dako, Glostrup,
Denmark) for 1 h at room temperature. They were then washed
and mounted in VECTASHIELD with DAPI (Vector Laborato-
ries, Burlingame, CA, USA). All photos were taken using a BZ-
9000 microscope (KEYENCE, Osaka, Japan).
Transplantation of donor cells
Balb/c nu/nu mice (7–9 weeks old) or Balb/c mice (7–9 weeks
old) were lethally irradiated (8 Gy) in a single fraction by a
137Cs c-
ray using a Gammacell 40 Exactor (MDS Nordion International
In Vivo NIRF Tracking of Cells
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into the recipient mice through the tail vein at 6–8 h after
irradiation. For ex vivo analyses of the chimerism of transplanted
EGFP
+ cells in the tibiae or peripheral blood, 1610
7 Cy5.5- or
AF750-labeled ICR/EGFP BM-MNCs were transplanted into the
Balb/c nu/nu mice. The recipient mice were sacrificed at 24, 48,
or 72 h. For in vivo imaging with congenic BMT, 1610
7 AF750-
labeled Balb/c nu/nu BM-MNCs were injected into the Balb/c
nu/nu mice. For allogeneic BMT, 1610
7 AF750-labeled C57BL/
6 BM-MNCs, 1610
7 AF750-labeled TCD C57BL/6 BM-MNCs,
or 5610
6 AF750-labeled C57BL/6 TCD BM-MNCs plus 5610
6
AF750-labeled C57BL/6 Sp-MNCs were injected into 7- to 9-
week-old Balb/c nu/nu mice.
IBM-BMT model
IBM-BMT was performed as described previously [14]. In brief,
7- to 9-week-old Balb/c nu/nu mice were lethally irradiated (8 Gy)
in a single fraction by a
137Cs c-ray 24 h before BMT. For IBM-
BMT, the mice were then anesthetized with isoflurane, and the left
tibia was gently drilled using a 26-G microsyringe (50 mL;
Hamilton, Reno, NV, USA) through the patellar tendon. The
AF750-labeled BM-MNCs (1610
7 in 30 mL PBS) were directly
injected into the BM cavity thereafter.
In vivo and ex vivo imaging of transplanted mice
In vivo imaging was performed using an IVIS Spectrum system
(Xenogen, Alameda, CA, USA) at 5, 15, or 30 min and 1, 3, 6, 12, 18,
or 24 h after BMT. During imaging, the mice were kept on the
imaging stage under anesthesia with 2.5% isoflurane gas in oxygen flow
(2 L/min). Transplanted Cy5.5- or AF750-labeled cells were detected
using emission and excitation filters (excitation/emission: 640/700 for
Cy5.5-labeled cells, 710/780 for AF750-labeled cells). The conditions
were as follows: exposure time =5 s, lamp level = high, binning =
medium, field of view =12.9612.9 cm, and f/stop =1. Ex vivo
imaging was performed using the IVIS Spectrum system 24 h after
BMT, under the same conditions as for in vivo imaging. For free
NIRF injection, free Cy5.5 (625 ng) or AF750 (40 ng) in 100 mLT r i s
in PBS (10 mM), with the same fluorescence intensity as 1610
7 NIRF
BM-MNCs, was injected through the tail vein.
Statistical analysis
Student’s t tests were used to determine the statistical
significance. P,0.05 was considered significant.
Results
Direct NIRF labeling technique shows low cytotoxicity
Since most diseases associated with BMT are caused by
transplanted hematopoietic cells, it is very important to label all
the donor cells. Freshly harvested BM-MNCs from Balb/c nu/nu
mice were labeled with 0.4 mg/mL Cy5.5 and 0.1 mg/mL
AF750, which did not show obvious cytotoxicity or growth
inhibition (Supplemental Figs. S2 and S3). Furthermore, the NIRF
dyes did not affect the colony-forming efficiency at these
concentrations (Fig. 1A). BM-MNCs were efficiently labeled
regardless of cell size and diversity (Fig. 1B). Using the NIRF
dyes, homogeneous labeling on the cell surfaces was achieved
despite using a variety of cell populations (Fig. 1C).
Fluorescence on the cell surface is retained and does not
influence surface antigen recognition
Balb/c Sp-MNCs were double-stained with CFSE and NIRF
dyes, and their mean fluorescence intensity (MFI) was measured
every 24 h until 72 h using FACS (Fig. 1D). To activate and
expand Sp-MNCs, we cultured them with CD3/28 beads and
mIL-2. MFI of CFSE decreased by 1 log during the first 24 h,
while MFI of NIRF hardly changed for 24 h; it was halved
following cell division after 48 h. Because Sp-MNCs were
l a b e l e du s i n gt h es a m em e t h o d ,t h ed i f f e r e n c ei nM F Ib e t w e e n
CFSE and NIRF can be attributed to the faster fluorescence
decay of CFSE, as its excitationw a v e l e n g t hi si nt h ev i s i b l e
range, rather than a difference in dye retention time on the cell
surface. These results indicate that NIRF retains more stable
MFI than CFSE.
During in vivo fluorescence imaging, recipient mice received
approximately 20 excitations over a 24-h period. We confirmed
that repeated excitations did not influence cell viability (Supple-
mental Fig. S4) or the NIRF MFI on the cell surface
(Supplemental Fig. S5). It was also considered that precise
evaluation of the obtained fluorescence images would be
influenced by transfer of the NIRF dye from the donor cells to
neighboring recipient cells after BMT and that the NIRF dyes on
the cell surface would hinder recognition of cell surface markers.
To examine these possibilities, we co-cultured Balb/c-derived
Thy1.2
+ Sp-MNCs (NIRF labeled) and FVB/N-derived Thy1.1
+
cells for 3 h and examined their NIRF-labeling status and
recognition by corresponding antibodies using FACS. The cells
labeled with NIRF were recognized as Thy1.2
+. Co-cultured
Thy1.1
+ cells showed no increase in NIRF (Fig. 1E). These results
indicate that NIRF dyes were universally retained on the cell
surface and did not influence the recognition of cell surface
antigens, suggesting that in vivo fluorescence imaging with NIRF-
labeled cells would contribute to acquisition of spatiotemporal
information regarding donor cells shortly after BMT.
In vivo tracking of Cy5.5-labeled hematopoietic cells
during the first 24 h after BMT
Cy5.5-labeled Balb/c nu/nu BM-MNCs were transplanted to
the Balb/c nu/nu recipient mice. Since abdominal autofluores-
cence caused by food decreases the precision of in vivo imaging,
all mice were fasted before in vivo imaging to suppress
autofluorescence from food particles in the GI tract, (Supple-
mental Figs. S1 and S6). The Cy5.5 signal was observed from
both sides of the tibiae and spines at 5 min after BMT through
the tail vein (Supplemental Fig. S7). We further examined the
status of transplanted BM-MNCs with Cy5.5 labeling (Fig. 2) and
found that BM-MNCs from ICR/EGFP were homogeneously
labeled with Cy5.5 on the cell surface (Fig. 2A). FACS analysis
revealed that the EGFP
+ cells included all leukocyte fractions
(Fig. 2B).
To confirm whether the in vivo Cy5.5 signals from the tibia
(Supplemental Fig. S7) were derived from Cy5.5-labeled
transplanted BM-MNCs, we transplanted Cy5.5-labeled ICR/
EGFP BM-MNCs to the Balb/c nu/nu mice. Cy5.5 signals
were observed in the tibia 24 h after BMT; these signals
decreased thereafter (Fig. 2C). BM cells in the tibia were
flushed and then observed by fluorescence microscopy on the
same schedule as for in vivo imaging. We confirmed that the
Cy5.5 signals detected in the tibia 24 h after BMT were from
the transplanted BM-MNCs and belonged to the Cy5.5
+ and
EGFP
+ cell populations (Fig. 2C, upper row). The cell surface
Cy5.5 signal decreased throughout the experiment, probably
due to cell division (Fig. 2C), while the chimerism of the EGFP
+
cells increased rapidly (Fig. 2D). The NIRF signals emanating
from the transplanted donor cells decreased with inverse
proportion to cell division.
In Vivo NIRF Tracking of Cells
PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11114Figure 1. Evaluation of cytotoxicity and in vitro fluorescence intensity of NIRF labeling. (A) GM-CFUs, BFU-Es, and CFU-GEMMs were
counted (n=5); mean CFUs per 2610
4 BM-MNCs are shown. (B) FACS analysis of Balb/c nu/nu BM-MNCs labeled with Cy5.5 (0.4 mg/mL) and AF750
(0.1 mg/mL). (C) Representative fluorescence image of Cy5.5-labeled Balb/c nu/nu BM-MNCs. Bar =100 mm. (D) In vitro retention of NIRF and CFSE in
Balb/c Sp-MNCs for the indicated times after labeling (n=8). Sp-MNCs (1610
5) were seeded in a 96-well plate with phenol red-free RPMI 1640
medium containing CD3/28 beads and mIL2. Values are %MFI 6 SEM. Error bars are less than 1.1%. (E) AF750-labeled Balb/c Thy1.2
+ Sp-MNCs (1610
6)
(i) were mixed in a 1:1 ratio with unlabeled FVB/N Thy1.1
+ Sp-MNCs (1610
6) (ii) at 37uC for 3 h, and the AF750 intensity of Thy1.1
+ and Thy1.2
+ cells
was analyzed by FACS.
doi:10.1371/journal.pone.0011114.g001
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11114Figure 2. EGFP and Cy5.5 double-positive cells were detected in BM at 24 h after BMT. (A) Representative fluorescence image of Cy5.5-
labeled ICR/EGFP BM-MNCs. Green, EGFP; blue, DAPI; red, Cy5.5. (B) FACS analysis of Cy5.5-labeled ICR/EGFP BM-MNCs at 1 h after labeling. The EGFP
+
cells included all leukocyte fractions. (C) Analysis of Cy5.5 and EGFP double-positive cells in the tibiae at the indicated times. Recipient Balb/c nu/nu
mice (H-2
d) were transplanted with 1610
7 Cy5.5-labeled ICR/EGFP BM-MNCs (closed colony). In vivo fluorescence imaging of the right legs of mice
In Vivo NIRF Tracking of Cells
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revealed that the NIRF tracking approach is highly
sensitive
Next, we transplanted AF750-labeled ICR/EGFP BM-MNCs
into the Balb/c nu/nu mice to evaluate the sensitivity and
accuracy of our approach for tracking the homing process of
donor cells in vivo. Distribution of the donor cells was monitored
using an in vivo imaging device for 24 h after BMT. Using AF750-
labeled cells, transplanted cells were detected in many organs in
vivo (Fig. 3A). The distribution of donor cells was spread over
several organs including the lung, liver, spleen, and BM (Fig. 3B).
Ex vivo imaging of the recipient mice at 24 h after BMT
confirmed NIRF signal distribution in the tissues suggested by in
vivo imaging (Fig. 3C). Significant NIRF signals were detected in
BM and the reticuloendothelial system, but not in the GI tract
(Fig. 3C). To confirm the presence of donor cells in the tissues
detected by ex vivo fluorescent imaging, sections of the tissues were
examined for presence of EGFP
+ cells 24 h after transplantation
(Fig. 3D). Although significant fluorescent signals were detected in
the tissues by in vivo and ex vivo imaging, the EGFP
+ cells were
sparsely distributed in each tissue, indicating that in vivo NIRF
imaging is highly sensitive.
In vivo and ex vivo tracking of AF750-labeled cells in
various congenic BMT models in an initial phase after
transplantation
The above results strongly suggest that in vivo imaging of
NIRF-labeled donor cells would provide a highly sensitive and
accurate method to track the homing process of transplanted cells.
First, congenic BMT was performed to evaluate the homing
process of transplanted cells in the absence of rejection.
Biodistributions of the transplanted BM-MNCs labeled with
AF750 were then compared in various congenic BMT models at
an early stage after transplantation. The AF750 images obtained
after injection of NIRF-unlabeled BM-MNCs were identical to
those of the background signals in PBS-injected mice (Supple-
mental Fig. S8). After intravenous injection of free AF750, the
fluorescent signal disappeared through the urinary system within
1 h after BMT (Supplemental Fig. S8). In the congenic BMT
model mice, the fluorescent signal was detectable in both tibiae
5 min after transplantation. It gradually increased by 3 h and
remained unchanged for the rest of the observation period (Fig. 4A,
supine position). We detected transplanted cell homing in vivo at
5 min after BMT, which is the earliest detection time reported
thus far. In the reticuloendothelial system, the transplanted cells
were first seen trapped in the lung 5 min after BMT and then in
the liver and spleen 15 min after BMT. In the IBM-BMT model,
the transplanted cells were seen trapped in the lung through the
peripheral circulation 5 min after IBM-BMT (Fig. 4A, supine
position). In this model, the donor cells migrated from the left tibia
to the right one within 1 h after BMT (Fig. 4A, supine position),
although many cells stayed in the left tibia for 24 h. Tissue
distribution of the fluorescent signal was examined by ex vivo
imaging 24 h after BMT in both BMT models. When the free
AF750 dye was injected intravenously, the background level
slightly increased in each organ, although the increase was
negligible (Fig. 4B). In a comparison of congenic BMT with
congenic IBM-BMT (Fig. 4B), most of the donor cells were found
to remain in the injected left tibia in congenic IBM-BMT mice,
while most of the donor cells migrated to all bones of the body in
the congenic BMT mice. To our knowledge, this is the first report
using in vivo imaging to reveal the distribution dynamics of
transplanted cells after IBM-BMT, and the results suggest that the
NIRF labeling approach would be applicable in various congenic
BMT models.
Transplanted donor cell division starts more than 24 h
after BMT
To determine the start time of transplanted donor cell division
after homing, we harvested the cells from the tibiae and peripheral
blood of the recipient mice at 24, 48, and 72 h after transplantation
of AF750-labeled ICR/EGFP BM-MNCs and examined the
fraction of EGFP
+ cells present by FACS (Fig. 5A). The NIRF
intensity of EGFP
+ cells 24 h after BMT was similar to that of
preBMT cells (Figs. 5A, B second row), indicating that the donor
cells had not started cell division until then because NIRF intensity
decreased with cell division (Fig. 1D, Supplemental Fig. S3). Donor
cell division started thereafter because the chimerism of EGFP
+ cells
in the tibiae of the recipients increased by approximately 45% at
72 h after BMT (Figs. 5B, C). FACS analysis revealed that the
donor cell population contained all leukocyte fractions at 72 h after
BMT (Fig. 5B, top right panel) and that EGFP
+ appeared in the
peripheral blood at 72 h with similar fluorescence intensity as that
in BM (Fig. 5D, Supplemental Fig. S9).
Immunohistochemical analysis confirmed that the number of
transplanted EGFP
+ cells did not increase until 24 h after BMT
and then rapidly expanded in the epiphyseal area of the tibia and
femur between 48 and 72 h after BMT (Figs. 5E, F). These results
indicate that transplanted donor cell division starts more than 24 h
after BMT and that hematopoietic reconstitution in Balb/c nu/nu
recipient mice begins approximately 72 h after BMT.
In vivo and ex vivo tracking of AF750-labeled cells in
various allogeneic BMT models
We attempted to visualize the biodistribution of allogeneic BMT
models with C57BL/6 (as donors) and Balb/c nu/nu mice (as
recipients) to analyze the onset of aGVHD. Because the depletion
of donor T cells abrogates GVHD [15], TCD-BMT (nonGVHD)
and TCD-BMT plus Sp-MNCs (GVHD) transplantation models
were established. In allogeneic BMT and the GVHD models, the
fluorescent signals from the reticuloendothelial system were very
high at 24 h after BMT (Fig. 6A, right top and bottom panels).
The tissues with a high fluorescent signal were confirmed by ex
vivo imaging 24 h after BMT (Fig. 6B). Among the reticuloendo-
thelial system, the fluorescence was lowest in the nonGVHD
model and highest in the GVHD model (Fig. 6B). These results
indicate that the presence of a T-cell population in the donor cells
causes homing to the reticuloendothelial system and that the TCD
donor cells predominantly homed to BM. The fluorescent signal
was very weak in the intestinal tract in all allogeneic BMT models
(Fig. 6B, bottom row).
Discussion
To our knowledge, this study is the first report describing the
use of in vivo real-time imaging to visualize the distribution
dynamics of transplanted BM cells in the entire body during the
transplanted with Cy5.5-labeled BM-MNCs obtained from ICR/EGFP mice is shown (left column). The cells from the tibiae were observed under an
inverted fluorescent microscope (right column). Bar =40 mm. Green, EGFP; blue, DAPI; red, Cy5.5. (D) FACS analysis of chimerism of Cy5.5 and EGFP
double-positive cells in the tibiae at the indicated times.
doi:10.1371/journal.pone.0011114.g002
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PLoS ONE | www.plosone.org 6 June 2010 | Volume 5 | Issue 6 | e11114Figure 3. Fluorescent signals from AF750/EGFP double-positive cells were detected in vivo with extremely high sensitivity. Lethally
irradiated Balb/c nu/nu (H-2
d) mice were transplanted with 1610
7 AF750-labeled ICR/EGFP BM-MNCs. (A) Sources of NIRF signals in vivo. The
congenic BMT model is shown as an example. (B) Representative in vivo images of the recipient mice at the indicated times after BMT. The prone
(upper row) and supine (bottom row) positions are shown. (C) Ex vivo imaging of the recipient mice. Mice transplanted with AF750-labeled (left) or
unlabeled (right) BM-MNCs were sacrificed at 24 h after BMT. The congenic AF750-unlabeled BMT model is shown as a control. (D) Fluorescence
images of various organs from recipient mice. AF750-labeled ICR/EGFP BM-MNCs were transplanted, and the organs were examined 24 h after
In Vivo NIRF Tracking of Cells
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11114initial phase after BMT using the NIRF method. Achieving in vivo
imaging at a very early stage after BMT was previously difficult
because the small number of cells that escape the reticuloendo-
thelial system result in minute cell distributions within each organ.
In this study, we labeled the surface of transplanted cells with
NIRF and successfully demonstrated the altered distribution
dynamics of transplanted cells in the initial phase. We could
noninvasively track transplanted cells circulating in the entire body
during the initial stage after BMT because of the following
reasons: (1) NIRF illumination with higher light propagation and
lower attenuation through the tissue was used as both excitation
and emission light for imaging [16]; (2) homogeneous labeling on
the cell surface with NIRF dyes was achieved despite a variety of
cell populations; (3) NIRF-labeled transplanted donor cells had a
constant MFI, detectable in vivo over a 24-h period; (4) Balb/c
nu/nu mice (hairless mice) were used to enhance NIRF signal
Figure 4. In vivo imaging of transplanted AF750-labeled donor cells in various congenic BMT models. (A) In vivo imaging of congenic
BMT models until 24 h after BMT. In the congenic BMT model, the transplanted cells were detected in the tibiae at 5 min after congenic BMT (supine
position). In the congenic IBM-BMT model, the migrating cells from the left tibia were detected 1 h after congenic IBM-BMT. The parts of the body
with significantly increased signals (indicated by squares) were magnified and are shown below the corresponding whole-body images. (B) Ex vivo
imaging of transplanted AF750-labeled donor cells in the BMT models at 24 h after BMT.
doi:10.1371/journal.pone.0011114.g004
BMT. Untreated Balb/c nu/nu mice were used as controls. Green, EGFP; blue, DAPI. White arrows show EGFP/DAPI double-positive cells. Bar
=100 mm.
doi:10.1371/journal.pone.0011114.g003
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PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11114Figure 5. Homing donor cells start cell division at least 24 h after BMT. (A) FACS analysis of AF750-labeled donor ICR/EGFP BM-MNCs was
performed immediately after labeling. (B) Chimerism of the transplanted donor AF750/EGFP double-positive cells in the tibiae. Lethally irradiated
Balb/c nu/nu recipients (H-2
d) were transplanted with 1610
7 AF750-labeled ICR/EGFP BM-MNCs. The cells in the tibiae were harvested, and EGFP
+
cells were analyzed by FACS at the indicated times after BMT. (C) Mean% 6 SEM of EGFP
+ cells in the recipient tibiae at the indicated times after BMT
In Vivo NIRF Tracking of Cells
PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e11114detection sensitivity; and (5) our original fasting protocol
successfully excluded autofluorescence derived from food particles,
the major obstacle in precise imaging of the abdomen.
Balb/c nu/nu mice lack the whn gene [17,18], which encodes a
forkhead/winged-helix transcription factor confined to expression
in the thymic epithelium, epidermis, and hair follicles. As a result
of the whn gene deficiency, Balb/c nu/nu mice lack the thymus
and post-thymic mature T cells [19]. However, this gene is not
expressed in HSCs [20], and reduction in the function of antigen-
presenting cells such as macrophages and dendritic cells of Balb/c
nu/nu mice has not been reported. Therefore, there is little
possibility that their genetic defect influences early transplantation
events such as homing of HSCs or antigen presentation in GVHD.
Abdominal autofluorescence caused by food disturbs precise
evaluation of in vivo imaging. To suppress autofluorescence from
food particles in the GI tract, all mice were fasted according to our
original fasting protocol prior to in vivo imaging (Supplemental
Fig. S1). As a result of fasting, the autofluorescence of the GI tract
was dramatically attenuated in vivo and ex vivo (Supplemental
Fig. S6). Obvious fasting-related organ damage was not apparent
in these mice (Supplemental Fig. S6).
Homing of AF750-labeled donor cells in the tibiae was detected
less than 1 h after BMT in the congenic BMT model. Signals from
the tibia were noted at 3 h after transplantation and continued to
rise until 24 h after transplantation. IBM-BMT is a method of
transplanting HSCs and stromal cells directly into niches in the
BM cavity [21,22], and the kinetics and homing of the
transplanted cells to all the bones of the body after IBM-BMT
have not been determined previously. In this study, we elucidated
that most of the transplanted cells remained within the injected
tibia, while some cells entered the peripheral circulation though
the BM sinus of the tibia, and cells trapped in the lung were
observed 5 min after IBM-BMT. Moreover, circulating cells
started migrating to the backbone and the collateral tibia of the
injected site 1 h after IBM-BMT.
FACS analysis using ICR/EGFP as donors revealed that
transplanted donor cells started cell division more than 24 h after
BMT and that hematopoietic reconstitution in Balb/c nu/nu mice
Figure 6. In vivo imaging of transplanted AF750-labeled donor cells in various allogeneic BMT models. (A) In vivo imaging of allogeneic
BMT models until 24 h after BMT. Conditioned Balb/c nu/nu recipients (H-2
d) received 1610
7 AF750-labeled C57BL/6 BM-MNCs (H-2
b) (upper row),
1610
7 TCD C57BL/6 BM-MNCs (middle row), or 5610
6 C57BL/6 TCD BM-MNCs plus 5610
6 C57BL/6 Sp-MNCs (bottom row). Areas indicated by
squares are magnified and shown below each image. (B) Ex vivo imaging of transplanted AF750-labeled donor cells in various allogeneic BMT models
at 24 h after BMT.
doi:10.1371/journal.pone.0011114.g006
(n=4). (D) The chimerism of EGFP
+ cells in the peripheral blood of the mice in (B) was analyzed by FACS. (E, F) Representative fluorescence images of
the tibiae (E) and femora (F). The bones were removed from the mice at the indicated times after BMT. Slices (3-mm thick) of the tibial and femoral
epiphyses were observed with an inverted fluorescent microscope. Donor EGFP
+ cells rapidly expanded in the tibial and femoral epiphyses between
48 and 72 h after BMT. Untreated Balb/c nu/nu mice were used as controls. Green, EGFP; blue, DAPI. Bar =100 mm.
doi:10.1371/journal.pone.0011114.g005
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that donor cell homing must have had started within 24 h after
BMT. Therefore, it is very important to understand both the
homing process of HSCs and mechanisms of engraftment failure
for accurate assessment of transplanted donor cell distribution
during the very initial phase after BMT.
With regard to aGVHD, Peyer’s patches (gut-associated
secondary lymphoid organs) are the initial sites of aGVHD
[23,24], and it has been previously reported that the infiltration of
donor cells into Peyer’s patches rapidly increased around 3 days
after BMT in murine GVHD models [8]. Furthermore,
splenectomy and prevention of T-cell entry into all secondary
lymphoid organs with aMAdCAM-1 and aCD62L monoclonal
antibodies abrogated the onset of gut GVHD [25]. Considering
these reports, gut GVHD would begin within 72 h after BMT,
and involvement of all secondary lymphoid organs may be
necessary to evoke gut GVHD. Our results regarding the
allogeneic BMT and GVHD models revealed that the donor cells
were barely detected in the intestinal tract within 24 h, and very
few instances of direct homing to Peyer’s patches were detected in
the allogeneic BMT models. On the other hand, a large number of
cells were found trapped in the lung, liver, spleen, and superficial
lymph nodes within 24 h after BMT (Fig. 6). Considering these
observations, it seems that a larger number of cells was present in
the reticuloendothelial system than in Peyer’s patches until 24 h
after BMT and that the secondary infiltration of T cells from
secondary lymphoid organs to Peyer’s patches is also considered to
be very important for induction of gut GVHD.
The mechanisms of hematopoietic cell homing have not been
revealed. It is assumed that the homing of hematopoietic cells is
caused by molecular interactions of transplanted cells with their
niche components [26,27] and that homing processes are varied
among hematopoietic cell populations [28]. As for lymphocytes,
high endothelial venules in lymph nodes or secondary lymphoid
tissues contribute to continuous immune surveillance by support-
ing lymphocyte recruitment from the blood [29,30]. Our results
clearly revealed that in the initial phase after BMT, the cell
distributions were varied among BMT models. For example, in
GVHD models, a T-cell population dominantly homed to the
reticuloendothelial system, whereas TCD donor cells dominantly
homed to BM (Fig. 6B). Using TCD BM-MNCs, which contained
less lymphocytes and more hematopoietic cells including HSCs,
we demonstrated that transplanted cells primarily homed to BM
and secondarily homed to lymphoid organs, including the
reticuloendothelial system (Fig. 6B).
In this study, we labeled the surface of transplanted cells with
NIRF and successfully demonstrated their altered distribution
dynamics during the initial phase. There are several transgenic
murine models with unique HSCs or BM microenvironments.
Our method may be useful to obtain spatiotemporal information
of the donor cell homing process in these mice. Together with
other optical imaging techniques such as bioluminescence
imaging, we believe that this method would provide a means to
study the pivotal process of complications associated with BMT,
such as engraftment failure and GVHD, and would contribute to
improvement of therapeutic outcomes of BMT.
Supporting Information
Figure S1 (A) Our original fasting protocol. (B) Autofluorescence
of the feed and stool of Balb/c mice. Autofluorescence of each
solution (C) and compositions (D) of solutions. (E) Evaluation of %
body weight change of fasting Balb/c mice (OS-1 versus H2O)
(n=5). (F) Survival curve of mice in (E) (n=5).
Found at: doi:10.1371/journal.pone.0011114.s001 (2.29 MB TIF)
Figure S2 The proportions of sub-G1 fractions of Balb/c nu/nu
BM-MNCs was analyzed by FACS at 2 h after labeling (n=5).
DNA content was analyzed as previously described [13]. The
population of cells with degraded genomic DNA (sub-G1 fraction)
was identified. Values are mean rates 6 SEM for the indicated
concentrations.
Found at: doi:10.1371/journal.pone.0011114.s002 (1.72 MB TIF)
Figure S3 Viable Balb/c Sp-MNCs were analyzed by a modified
MTT assay. Various concentrations of Cy5.5- or AF750-labeled
Sp-MNCs (16105) were seeded in a 96-well plate with phenol red-
free RPMI 1640 medium containing CD3/28 beads and mIL2
(n=5). The cells were then incubated for the indicated times. At the
end of the culture period, the viable cell number was analyzed as
previously described [12] with slight modifications. The absorbance
(450 nm) was measured 3 h after adding the cell-counting reagent.
The experiments were done in at least triplicate, and results are
presented as the mean relative OD 6 SEM.
Found at: doi:10.1371/journal.pone.0011114.s003 (1.73 MB TIF)
Figure S4 The proportions of sub-G1 fractions caused by a
single fraction of near-infrared excitation and emission. NIRF-
labeled or unlabeled Balb/c nu/nu BM-MNCs were excited for
5 s using the IVIS (Cy5.5: 640 nm, AF750: 710 nm) and the sub-
G1 fractions were analyzed by FACS at 2 h after excitation (n=5).
Found at: doi:10.1371/journal.pone.0011114.s004 (1.77 MB TIF)
Figure S5 FACS analysis for the decrement of mean fluores-
cence intensity (MFI) by repeated excitations. NIRF-labeled Balb/
c nu/nu BM-MNCs were excited for 5 s per excitation using the
IVIS (n=5). The MFIs of NIRF-labeled BM-MNCs were
analyzed by FACS at 2 h after repeated excitation for the
indicated times.
Found at: doi:10.1371/journal.pone.0011114.s005 (0.89 MB TIF)
Figure S6 (A,B) Autofluorescence in the abdomen was signifi-
cantly reduced by the original fasting protocol. (C) Histological
analyses (H&E staining) of the indicated organs in fasted mice on
day 1. Fasting-related organ damage was not apparent in the
fasting mice. Bar =100 mm.
Found at: doi:10.1371/journal.pone.0011114.s006 (2.62 MB TIF)
Figure S7 In vivo imaging of transplanted Cy5.5-labeled donor
cells. In vivo imaging of Cy5.5-labeled Balb/c nu/nu BM-MNCs
with mice in the supine and prone positions. Signals for the
transplanted Cy5.5-labeled cells were seen in the backbone and
the tibia. The areas indicated by squares are magnified and are
shown below each image.
Found at: doi:10.1371/journal.pone.0011114.s007 (3.57 MB TIF)
Figure S8 In vivo imaging of transplanted AF750-labeled donor
cells. Conditioned recipients were injected with indicated solutions.
Found at: doi:10.1371/journal.pone.0011114.s008 (2.23 MB
TIF)
Figure S9 Donor EGFP+ cells appeared in the peripheral blood
at 72 h with similar fluorescence intensity to that in the BM.
Purple, donor cells; Black, recipient cells.
Found at: doi:10.1371/journal.pone.0011114.s009 (1.15 MB TIF)
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